Navigation Links
CHEST 2011: Embargoed studies highlight new lung health research
Date:10/23/2011

y a few times, while 22% experienced recurring pain, mainly in the shoulder, back, wrist, neck, and thumb. The pain appeared to be associated with overuse injury and height less than 5'7". Of those feeling pain, 80% sought no treatment and only 38% attempted to modify their workspace. Measures may be necessary to prevent musculoskeletal injuries for bronchoscopists.

Combination Therapy Shows Promise for PAH Treatment
(#1080799, Wednesday, October 26, 3:00 PM Eastern)

Current treatments for pulmonary arterial hypertension (PAH) often entail observing patient deterioration when using a single medication and seeing its effects before starting a second medication. Researchers from Calgary, AB, Canada conducted clinical trials on high-risk patients with a mean age of 60 years who had idiopathic and connective tissue disease-associated PAH. The researchers administered a first-line oral combination therapy of bosentan and sildenafil, which yielded improvements in 6-min walk test, symptoms, and blood flow and cardiac function parameters. This strategy appears to be relatively safe and well tolerated by the patients in this study. However, the magnitude and durability of clinical improvements along with the risks of early drug-induced liver damage remain unclear and warrant further study.

Catheter-Related Bloodstream Infections Significantly Decreased After Guideline Implementation
(#1108555, Tuesday, October 25, 3:00 PM Eastern)

Evidence-based guidelines have been shown to improve health-care outcomes. In 2006, a guideline called the Institute of Health Improvement Bundle was created to help hospitals reduce the rate of catheter-related bloodstream infection (CRBSI), the most frequently occurring nosocomial infection. Researchers from the Spinal Cord Injury Center (SCI) at the James A. Haley Veterans Hospital and the University of South Florida, both in Tampa, retrospectively reviewed the charts of 895 patients admitted
'/>"/>

Contact: Sue Roberts
sroberts@chestnet.org
847-498-8334
American College of Chest Physicians
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. New cardiology research presented at CHEST 2008
2. Unexplained chest pain can be due to stress
3. Study finds most wars occur in Earths richest biological regions
4. Molecules that orchestrate the processes of life
5. Tennessee foresters helping to return chestnuts to American forests
6. Rochester study connects workplace turmoil, stress and obesity
7. Surgeons demonstrate new minimally invasive technique to correct chest deformity
8. University of Manchester academics at international conference on geographic chemicals
9. Helical CT scans reduce lung cancer mortality by 20 percent compared to chest X-rays
10. Manchester leads green chemical training push
11. Semporna may have richest marine biodiversity in the world
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... stretch them, twist them, fold them: modern materials that ... potential, whether as artificial skin or electronic paper. , ... a challenge but a new way of working with ... a game-changer. , Previous success in the field ... use of precious gold and silver nanowires. , ...
(Date:8/28/2014)... pleased to announce the selection of Dr. Fred Baxendale ... acknowledges those who have served ESA for at least ... the Society that has reached an extraordinary level. Candidates ... Board and then voted on by the ESA membership. ... at Entomology 2014, ESA,s Annual Meeting in Portland, Oregon ...
(Date:8/28/2014)... news release is available in German . ... water fish, owes its name to a striking pattern of ... types, black cells, reflective silvery cells, and yellow cells emerge ... and arrange as a multilayered mosaic to compose the characteristic ... three cell types have to interact to form proper stripes, ...
Breaking Biology News(10 mins):Copper shines as flexible conductor 2Fred Baxendale selected as Honorary Member of the Entomological Society of America 2How the zebrafish gets its stripes 2How the zebrafish gets its stripes 3
... in German . , Researchers at the Max ... the Czech Academy of Sciences in Prague have developed a new ... acids, amino acids and other organic substances from plant or animal ... liter -- is sufficient to identify certain blood related metabolites. ...
... of fishing gear could help the world,s coral reefs and their ... team of scientists led by Dr Josh Cinner of the ARC ... has proposed that bans on fishing gear - like spear guns, ... in the recovery of reefs and fish populations hard hit by ...
... Although worlds apart, the way fish learn could be ... a new research study. A common species of fish ... nine-spined stickleback, could be the first animal shown to exhibit ... compare the behaviour of other sticklebacks with their own experience ...
Cached Biology News:An easy way to find a needle in a haystack by removing the haystack 2An easy way to find a needle in a haystack by removing the haystack 3Gear bans 'can help save reefs' 2Gear bans 'can help save reefs' 3Common fish species has 'human' ability to learn 2Common fish species has 'human' ability to learn 3
(Date:8/29/2014)... 2014 The global companion diagnostics ... 2019. It is expected to grow at a ... was valued at $1.8 billion in 2013, according ... Research. , For more information regarding analysis details ... The research report, titled “Companion Diagnostics Market (Breast ...
(Date:8/29/2014)... Hills, NY (PRWEB) August 29, 2014 ... Burnt Hills Veterinary Hospital are seeking candidates to participate ... dogs with osteoarthritis. The ultimate goal of this ... donor stem cells into one or two arthritically affected ... treated joints. , Candidates for the current investigational ...
(Date:8/29/2014)... Boston, MA, San Antonio, TX (PRWEB) August 29, ... audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® ... it has been awarded an international Phase II ... patients with non-Hodgkin’s lymphoma. , Throughout this trial, ... services including, but not limited to, protocol and ...
(Date:8/28/2014)... 2014 “This kit has an improved extraction ... 0 to 150 ppb,” said Mark Tess, PhD, Mycotoxin Product ... to plant owners and USDA-GIPSA inspection agencies that have a ... can take place in a matter of minutes with nothing ... test the feed and grain before accepting it, but they ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... Corporation,s (Amex: ETC ) ("ETC" or the ... contract with the Netherlands,Institute for Safety, NIFV, to ... Simulator for Aircraft Rescue Fire Fighting., The ... military helicopter,scenario consisting of AH-64 Apache helicopters parked ...
... FRANCISCO, Calif., Nov. 3 Portola,Pharmaceuticals, a ... advances in cardiovascular and inflammatory,diseases, and cancer, ... enrollment,in a large Phase II clinical trial ... inhibitor anticoagulant, for stroke prevention in patients ...
... Therapeutics, Inc.,(Nasdaq: HALO ), a biopharmaceutical ... matrix, today announced it has started,a Phase ... enzyme,(rHuPH20) co-formulations with Humulin(R) R (regular insulin ... Type 1 diabetic,patients. This study is designed ...
Cached Biology Technology:Environmental Tectonics Corporation's Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety 2Environmental Tectonics Corporation's Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety 3Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation 2Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation 3Portola Pharmaceuticals Initiates Phase II Trial of Betrixaban, its Novel Oral Factor Xa Inhibitor for Stroke Prevention in Atrial Fibrillation 4Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients 2Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients 3Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients 4
Edited by P.J. Delves (1997) An up-to-date review of antibody-raising technologies, this volume provides researchers with immediate access to the protocols they require every day....
Request Info...
MOUSE ANTI HUMAN FACTOR I...
albumin from bovine serum (BSA), tetramethylrhodamine conjugate...
Biology Products: